about
Strategies to target tumors using nanodelivery systems based on biodegradable polymers, aspects of intellectual property, and marketMultifunctional materials for bone cancer treatment.Controlled release of paclitaxel from a self-assembling peptide hydrogel formed in situ and antitumor study in vitroHighly porous drug-eluting structures: from wound dressings to stents and scaffolds for tissue regenerationMaterials for pharmaceutical dosage forms: molecular pharmaceutics and controlled release drug delivery aspectsMolecular buckets: cyclodextrins for oral cancer therapy.Effect of formulation parameters on 2-methoxyestradiol release from injectable cylindrical poly(DL-lactide-co-glycolide) implants.Intratumoral administration of paclitaxel in an in situ gelling poloxamer 407 formulation.Subcutaneous administration of nano- and microsuspensions of poorly soluble compounds to rats.Development and in vitro-in vivo evaluation of polymeric implants for continuous systemic delivery of curcumin.PhytoNanotechnology: Enhancing Delivery of Plant Based Anti-cancer Drugs.Paclitaxel-eluting composite fibers: drug release and tensile mechanical properties.Controlled release of paclitaxel from biodegradable unsaturated poly(ester amide)s/poly(ethylene glycol) diacrylate hydrogels.Efficacy of a metallic stent covered with a paclitaxel-incorporated membrane versus a covered metal stent for malignant biliary obstruction: a prospective comparative study.Antitumor effect of the paclitaxel-eluting membrane in a mouse modelPaclitaxel-loaded microparticles for intratumoral administration via the TMT technique: preparation, characterization, and preliminary antitumoral evaluation
P2860
Q27015050-E1A272D2-611E-464A-A9F3-BB4BFCE7CB2AQ33709363-488BBB03-C954-405F-BCC1-0DAC0DE7006CQ35547208-1484DF13-291C-4B5A-9610-F425F52AB004Q36597457-BB09B3F0-3174-4360-82A7-4FC09BD1B247Q37801284-5E6A9491-16E5-423A-BFB1-04682C58809FQ38029632-B2AABAF2-3743-4E5C-8294-A759000C7595Q40093045-5626C147-F8FE-4FC3-B401-58A454511174Q44029377-40F95DE5-7BB3-48B6-8AFC-47B970C29775Q44888499-7BEDD070-6630-42A5-8EA7-DD4CB6123609Q45770364-3D0BE1FF-F0D1-4A2C-A40A-47696D3393D9Q50233354-D8748F29-4F97-447A-B826-3AE303261363Q50962970-EB4BFB9D-D842-468D-9F4E-8A7ACC4D0BA5Q50986911-995A6A4B-A632-468D-842C-F56BDAD4CF36Q51294262-03921B5F-A317-41E2-8F47-8CF1FEF5DB9DQ57107283-0277BEBF-78B7-4368-938D-5CDE920238CDQ57186401-3C2BAA51-9150-4AA1-90E6-43FA8606CEAC
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Localized paclitaxel delivery.
@ast
Localized paclitaxel delivery.
@en
type
label
Localized paclitaxel delivery.
@ast
Localized paclitaxel delivery.
@en
prefLabel
Localized paclitaxel delivery.
@ast
Localized paclitaxel delivery.
@en
P1476
Localized paclitaxel delivery.
@en
P2093
Dhanikula AB
Panchagnula R
P304
P356
10.1016/S0378-5173(99)00087-3
P407
P577
1999-06-01T00:00:00Z